Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.100 +0.030 (+1.45%)

Delayed Quote Updated: 1:37 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 05, 2023

Via Benzinga

Aytu BioPharma Announces 1-for-20 Reverse Stock Split

January 05, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 26, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 26, 2022

Via Benzinga

Muscle Maker And 2 Other Stocks Under $1 Insiders Are Aggressively Buying ↗

December 22, 2022

The Dow Jones settled higher by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Second Year in a Row

November 17, 2022

Via ACCESSWIRE

Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023

November 14, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Agreement with Avenue Venture Debt Fund to Extend Interest-Only Period of Company's Term Loan

October 25, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect

November 30, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 23, 2022

Via Benzinga

Aytu BioPharma Receives a 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

November 22, 2022

Via ACCESSWIRE

Aytu BioPharma Announces the Passing of Co-Founder and Board Member Michael Macaluso

November 16, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Strategic Shift, Indefinite Suspension of Clinical Development Programs ↗

October 13, 2022

Via Benzinga

Aytu BioPharma Announces Continuing Availability of ADHD Medication Adzenys XR-ODT(R) in Response to Reported Generic Adderall(R) XR Supply Disruptions

October 05, 2022

Via ACCESSWIRE

Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket ↗

November 09, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of...

Via Benzinga

Aytu BioPharma to Report First Quarter Fiscal 2023 Financial Results on November 14, 2022

November 07, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 13, 2022

Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 24.6% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $17.1 million.

Via Benzinga

Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue

September 27, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin

September 14, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Strategic Shift to Focus on Commercial Operations and Indefinite Suspension of Clinical Development Programs

October 13, 2022

Via ACCESSWIRE

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 05, 2022

Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.

Via Benzinga

Aytu BioPharma's Return On Capital Employed Insights ↗

September 28, 2022

According to data from Benzinga Pro, during Q4, Aytu BioPharma's (NASDAQ:AYTU) reported sales totaled $27.45 million. Despite a 66.65% increase in earnings, the company posted a loss of $17.70...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

Earnings Scheduled For September 27, 2022 ↗

September 27, 2022

Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is projected to report quarterly earnings at $2.79 per share on revenue of $7.86 billion.

Via Benzinga

Aytu BioPharma's Earnings: A Preview ↗

September 26, 2022

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Aytu...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022

September 20, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 29, 2022

Via Benzinga

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday ↗

August 30, 2022

Gainers

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.